A Double-Edged Sword: The Two Faces of PARylation

被引:22
|
作者
Kang, Mincheol [1 ]
Park, Seojin [1 ]
Park, Seong-Hoon [2 ]
Lee, Hee Gu [3 ]
Park, Jun Hong [1 ]
机构
[1] Korea Inst Oriental Med, Herbal Med Resources Res Ctr, Naju Si 58245, South Korea
[2] Korea Inst Toxicol, Genet & Epigenet Toxicol Res Grp, Daejeon 34141, South Korea
[3] Korea Res Inst Biosci & Biotechnol, Immunotherapy Res Ctr, Daejeon 34141, South Korea
关键词
PARylation; poly(ADP-ribose) polymerases (PARPs); ADP-ribose; NAD(+); protein post-translational modifications; HIGH-FAT DIET; POLY(ADP-RIBOSE) POLYMERASE; DNA-DAMAGE; POSTTRANSLATIONAL MODIFICATIONS; CHROMATIN-STRUCTURE; CELL-DEATH; PARP-1; NAD(+); EXPRESSION; REPAIR;
D O I
10.3390/ijms23179826
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Poly ADP-ribosylation (PARylation) is a post-translational modification process. Following the discovery of PARP-1, numerous studies have demonstrated the role of PARylation in the DNA damage and repair responses for cellular stress and DNA damage. Originally, studies on PARylation were confined to PARP-1 activation in the DNA repair pathway. However, the interplay between PARylation and DNA repair suggests that PARylation is important for the efficiency and accuracy of DNA repair. PARylation has contradicting roles; however, recent evidence implicates its importance in inflammation, metabolism, and cell death. These differences might be dependent on specific cellular conditions or experimental models used, and suggest that PARylation may play two opposing roles in cellular homeostasis. Understanding the role of PARylation in cellular function is not only important for identifying novel therapeutic approaches; it is also essential for gaining insight into the mechanisms of unexplored diseases. In this review, we discuss recent reports on the role of PARylation in mediating diverse cellular functions and homeostasis, such as DNA repair, inflammation, metabolism, and cell death.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Redox regulation in cancer A double-edged sword with therapeutic potential
    Acharya, Asha
    Das, Ila
    Chandhok, Des
    Saha, Tapas
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2010, 3 (01) : 23 - 34
  • [42] FSTL1: A double-edged sword in cancer development
    Du, Ruijuan
    Li, Kai
    Guo, Kelei
    Chen, Zhiguo
    Han, Li
    Bian, Hua
    GENE, 2024, 906
  • [43] Alternatively activated macrophages; a double-edged sword in allergic asthma
    Abdelaziz, Mohamed Hamed
    Abdelwahab, Sayed F.
    Wan, Jie
    Cai, Wei
    Wang, Huixuan
    Cheng, Jianjun
    Kumar, Kesavan Dinesh
    Vasudevan, Aparna
    Sadek, Ahmed
    Su, Zhaoliang
    Wang, Shengjun
    Xu, Huaxi
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [44] Netrins as prophylactic targets in skeletal diseases: A double-edged sword?
    Maruyama, Kenta
    Takemura, Naoki
    Martino, Mikael M.
    Kondo, Takeshi
    Akira, Shizuo
    PHARMACOLOGICAL RESEARCH, 2017, 122 : 46 - 52
  • [45] Autophagy, a double-edged sword in anti-angiogenesis therapy
    Liu, Jiatao
    Fan, Lulu
    Wang, Hua
    Sun, Guoping
    MEDICAL ONCOLOGY, 2016, 33 (01) : 1 - 13
  • [46] Autophagy-driven NETosis is a double-edged sword - Review
    Liang, Xiaofei
    Liu, Li
    Wang, Yan
    Guo, Haipeng
    Fan, Hua
    Zhang, Chao
    Hou, Lili
    Liu, Zhibo
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 126
  • [47] LEP and LEPR are possibly a double-edged sword for wound healing
    Zhang, Kai-Wen
    Jia, Yuan
    Li, Yue-Yue
    Guo, Dan-Yang
    Li, Xiao-Xiao
    Hu, Kai
    Qian, Xiao-Xi
    Chen, Zhong-Hua
    Wu, Jun-Jie
    Yuan, Zheng-Dong
    Yuan, Feng-Lai
    JOURNAL OF CELLULAR PHYSIOLOGY, 2023, 238 (02) : 355 - 365
  • [48] Ferroptosis: a double-edged sword mediating immune tolerance of cancer
    Dang, Qin
    Sun, Ziqi
    Wang, Yang
    Wang, Libo
    Liu, Zaoqu
    Han, Xinwei
    CELL DEATH & DISEASE, 2022, 13 (11)
  • [49] NKB cells: A double-edged sword against inflammatory diseases
    Tandel, Nikunj
    Negi, Sushmita
    Tyagi, Rajeev K.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [50] Toll-like receptor 3: a double-edged sword
    Hsieh, Marvin L.
    Nishizaki, Daisuke
    Adashek, Jacob J.
    Kato, Shumei
    Kurzrock, Razelle
    BIOMARKER RESEARCH, 2025, 13 (01)